Literature DB >> 20644905

[Pharmacogenetics].

H F Merk1.   

Abstract

Allergic reactions to drugs belong to the group of B-reactions, which are characterized not only by the pharmacologic profile of the drug but also by individual risk factors. Pharmacogenetic approaches facilitate identifying these risk factors. The most important example for Caucasian patients is NIDR (non-immediate drug reaction) to abacavir. Chinese patients possess risk factors for NIDR to allopurinol and anticonvulsants and the HLA locus on chromosome 6. Another potentially important area is assessing risk factors to prevent allergic reactions to antibiotics, especially with regard to the effective treatment of MRSA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20644905     DOI: 10.1007/s00105-010-1944-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  29 in total

1.  Pharmacogenetics in the laboratory and the clinic.

Authors:  David B Goldstein
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

Review 2.  Inheritance and drug response.

Authors:  Richard Weinshilboum
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

3.  Medical genetics: a marker for Stevens-Johnson syndrome.

Authors:  Wen-Hung Chung; Shuen-Iu Hung; Hong-Shang Hong; Mo-Song Hsih; Li-Cheng Yang; Hsin-Chun Ho; Jer-Yuarn Wu; Yuan-Tsong Chen
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

Review 4.  Priorities and standards in pharmacogenetic research.

Authors:  Anna C Need; Arno G Motulsky; David B Goldstein
Journal:  Nat Genet       Date:  2005-07       Impact factor: 38.330

Review 5.  [Pharmacogenetics: Important aspects for dermatology].

Authors:  H F Merk
Journal:  Hautarzt       Date:  2005-01       Impact factor: 0.751

6.  Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma.

Authors:  M Sanak; H U Simon; A Szczeklik
Journal:  Lancet       Date:  1997-11-29       Impact factor: 79.321

7.  Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil.

Authors:  M R Johnson; A Hageboutros; K Wang; L High; J B Smith; R B Diasio
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

Review 8.  Pharmacogenomics and individualized drug therapy.

Authors:  Michel Eichelbaum; Magnus Ingelman-Sundberg; William E Evans
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

Review 9.  Genetic factors in the predisposition to drug-induced hypersensitivity reactions.

Authors:  Munir Pirmohamed
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

Review 10.  Immunogenetics of drug-induced skin blistering disorders. Part II: synthesis.

Authors:  Clive Bowman; Olivier Delrieu
Journal:  Pharmacogenomics       Date:  2009-05       Impact factor: 2.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.